Group 1 - The company Yonghe Medical (02279.HK) announced changes in its nomination committee, with independent non-executive director Mr. Li Xiaopei stepping down and Ms. Liang Jihong being appointed as a member [1] - As of October 28, 2025, Yonghe Medical's stock closed at HKD 2.03, up 0.49%, with a trading volume of 138,500 shares and a turnover of HKD 278,000 [1] - The stock has low attention from investment banks, with no ratings given in the past 90 days [1] Group 2 - Yonghe Medical has a market capitalization of HKD 1.061 billion, ranking 24th in the medical services II industry [1] - Key financial metrics for Yonghe Medical compared to the industry average are as follows: - ROE: -7.3% vs. 0.02% (rank 40) - Market capitalization: HKD 1.061 billion vs. HKD 8.115 billion (rank 24) - Revenue: HKD 1.766 billion vs. HKD 3.832 billion (rank 18) - Net profit margin: 3.23% vs. -843.36% (rank 34) - Gross profit margin: 63.88% vs. 39.76% (rank 12) - Debt ratio: 54.06% vs. 74.15% (rank 36) [1]
雍禾医疗(02279.HK)：独立非执行董事梁继红获委任为提名委员会成员